PROTAC Bcl2 degrader-1

98%

  • Product Code: 55747
  CAS:    2378801-85-3
Molecular Weight: 941.84 g./mol Molecular Formula: C₄₅H₄₅BrN₆O₁₀S
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C
Product Description: This compound is primarily used in the field of cancer research and therapy. It functions as a Proteolysis Targeting Chimera (PROTAC) designed to target and degrade Bcl-2, a protein that plays a critical role in preventing apoptosis in cancer cells. By degrading Bcl-2, it promotes programmed cell death in malignant cells, making it a promising tool for developing treatments for Bcl-2-dependent cancers such as certain types of leukemia and lymphoma. Its application is particularly significant in overcoming resistance to traditional Bcl-2 inhibitors, offering a novel approach to cancer therapy. Research is ongoing to evaluate its efficacy, specificity, and potential for clinical use.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days ฿53,820.00
+
-
0.005 10-20 days ฿97,020.00
+
-
PROTAC Bcl2 degrader-1
This compound is primarily used in the field of cancer research and therapy. It functions as a Proteolysis Targeting Chimera (PROTAC) designed to target and degrade Bcl-2, a protein that plays a critical role in preventing apoptosis in cancer cells. By degrading Bcl-2, it promotes programmed cell death in malignant cells, making it a promising tool for developing treatments for Bcl-2-dependent cancers such as certain types of leukemia and lymphoma. Its application is particularly significant in overcoming resistance to traditional Bcl-2 inhibitors, offering a novel approach to cancer therapy. Research is ongoing to evaluate its efficacy, specificity, and potential for clinical use.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :